From 2006 to 2014, patients with chronic kidney disease (CKD) had a high prevalence of uncontrolled hypertension that did not decrease over time.

Use of specialized hypertension medications in patients with CKD did not increase over time.

Statins are underused in CKD patients with respect to guideline recommendations.